CX3CL1 and systemic lupus erythematosus: A 100 pg/ml greater concentration of Fractalkine/CX3CL1 almost halved the likelihood of pSS compared to SLE (OR = 0.534 and 95% CI [0.287–0.991]; p = 0.0466).